Manufacture of Oral and Topical Dosage Forms

Award Notice Posted

Solicitation number
N02CM57002-05
Agency
Awarded
to Societal Cdmo San Diego, LLC
Set-aside
No set-aside

Opportunity facts

Contract number
HHSN261201500009I-HHSN26100016 Federal contract award
PSC
Not on record
Place of performance
TBD - Contractor's facility, United States

Notice details come from SAM.gov. Updated .

Notice text

5 versions

Update #5 · Latest ·

Amendment #4 extends the due date for proposals until 3 PM eastern time on March 17, 2015

Update #4 ·

Amendment 3 extends the due date for proposals until 3PM eastern time March 16, 2015.

Update #3 ·

Amendment 2 provides answers to questions.  See attached amendment document.

Update #2 ·

Amendment #1 changes the due date for proposals to March 9, 2015 at 3 PM eastern time

Update #1 ·

The Developmental Therapeutic Program (DTP) of the Division of Cancer Treatment and Diagnosis (DCTD) is involved in discovery and development of new therapeutic agents for treatment of cancer. Molecules for development enter the system under various mechanisms such as NCI Experimental Therapeutics Program (NExT) and Chemical Biology Consortium (CBC). Current contract provides the NCI with pharmaceutical development and production of oral and topical dosage forms for use in clinical trials.

Files

Notice history

Notice Type Posted
Manufacture of Oral and Topical Dosage Forms Latest Award Notice
This notice Original Award Notice

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors